| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:04:44 UTC |
|---|
| Update date | 2020-02-24 19:10:15 UTC |
|---|
| Primary ID | FDB000861 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Diosmetin |
|---|
| Description | Diosmetin belongs to the class of organic compounds known as 4'-o-methylated flavonoids. These are flavonoids with methoxy groups attached to the C4' atom of the flavonoid backbone. Thus, diosmetin is considered to be a flavonoid. Diosmetin has been detected, but not quantified in, several different foods, such as common sages (Salvia officinalis), common thymes (Thymus vulgaris), citrus, lemon verbenas (Aloysia triphylla), and lemons (Citrus limon). This could make diosmetin a potential biomarker for the consumption of these foods. Based on a literature review a significant number of articles have been published on Diosmetin. |
|---|
| CAS Number | 520-34-3 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 3',5,7-Trihydroxy-4'-methoxyflavone | ChEBI | | 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone | ChEBI | | 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one | ChEBI | | Luteolin 4'-methyl ether | ChEBI | | Salinigricoflavonol | ChEBI | | 4'-Methylluteolin | HMDB | | 5,7,3'-Trihydroxy-4'-methoxyflavone | HMDB | | Vitamin P | HMDB | | Diosmetin | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C16H12O6 |
|---|
| IUPAC name | 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one |
|---|
| InChI Identifier | InChI=1S/C16H12O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-7,17-19H,1H3 |
|---|
| InChI Key | MBNGWHIJMBWFHU-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | COC1=C(O)C=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O |
|---|
| Average Molecular Weight | 300.2629 |
|---|
| Monoisotopic Molecular Weight | 300.063388116 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as 4'-o-methylated flavonoids. These are flavonoids with methoxy groups attached to the C4' atom of the flavonoid backbone. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Flavonoids |
|---|
| Sub Class | O-methylated flavonoids |
|---|
| Direct Parent | 4'-O-methylated flavonoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - 4p-methoxyflavonoid-skeleton
- 3'-hydroxyflavonoid
- 5-hydroxyflavonoid
- 7-hydroxyflavonoid
- Flavone
- Hydroxyflavonoid
- Chromone
- Benzopyran
- Methoxyphenol
- 1-benzopyran
- Phenoxy compound
- Anisole
- Methoxybenzene
- Phenol ether
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Phenol
- Pyranone
- Monocyclic benzene moiety
- Benzenoid
- Pyran
- Vinylogous acid
- Heteroaromatic compound
- Organoheterocyclic compound
- Ether
- Oxacycle
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Disposition | Route of exposure: Biological location: Source: |
|---|
| Role | Industrial application: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Not Available | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 64.00%; H 4.03%; O 31.97% | DFC |
|---|
| Melting Point | Mp 228-230° | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | 3.10 | PERRISSOUD,D & TESTA,B (1986) |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | 345 (e 21000) (MeOH) (Berdy) | DFC |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Diosmetin, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0kh9-0492000000-c9cb489c6e399645f54f | Spectrum | | Predicted GC-MS | Diosmetin, 3 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0ukc-2190860000-1029bf37ad921c9a81e8 | Spectrum | | Predicted GC-MS | Diosmetin, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - ESI-TOF 20V, Negative | splash10-014u-0000700009-50048523dd30a3c69126 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-014u-0000700009-50048523dd30a3c69126 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 50V, Negative | splash10-057i-0490000000-9c04ed66f8f3ed9e2ed8 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 40V, Negative | splash10-001i-0190000000-77edda567cd76512c52d | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 20V, Negative | splash10-001i-0090000000-675379707ad9e98244a9 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-0002-0091000000-188fb9f96e76251ce539 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 50V, Negative | splash10-057i-0490000000-9c04ed66f8f3ed9e2ed8 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 40V, Negative | splash10-001i-0190000000-77edda567cd76512c52d | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITTOF , negative | splash10-001i-0090000000-ae5188debe4910fab9c6 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , negative | splash10-001i-0090000000-6e1198f4157cda4df0ac | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , negative | splash10-001i-0090000000-b23157e3c53d703e88d1 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-001i-0090000000-675379707ad9e98244a9 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-057i-0490000000-9c04ed66f8f3ed9e2ed8 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-001i-0190000000-77edda567cd76512c52d | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-000i-0094000000-0b3f48256d5c0ee7fb1b | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QFT 21V, positive | splash10-000i-0092000000-0448ee3b6390176e376a | 2020-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-IT 21V, positive | splash10-000i-0090000000-8bb45858bd3dc65a5c07 | 2020-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 6V, Negative | splash10-0002-0190000000-15ab8c66562248b310ee | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-0a4i-0290000000-2ce24609e65e5b7d0d11 | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0udi-0009000000-a4a0986393c64d566f91 | 2015-04-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0udi-0019000000-9488c8767caac5f6b9b5 | 2015-04-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0ufr-2590000000-e4455d0da36912d7b96a | 2015-04-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0002-0090000000-91f51b4b036d4731f305 | 2015-04-25 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0002-0090000000-b6f4a2a03e7355f95b1c | 2015-04-25 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0ue9-0390000000-e296a45296f81b0f1454 | 2015-04-25 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 4444931 |
|---|
| ChEMBL ID | CHEMBL90568 |
|---|
| KEGG Compound ID | C10038 |
|---|
| Pubchem Compound ID | 5281612 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 4630 |
|---|
| Phenol-Explorer ID | 241 |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB29676 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | BKL03-G:BKL03-G |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | DIOSMETIN|VITAMIN-P |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00001036 |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Not Available |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Aldose reductase inhibitor | 48550 | An agent that blocks the activity of aldose reductase, an enzyme involved in glucose metabolism. It reduces oxidative stress and inflammation, commonly used in managing diabetic complications, such as neuropathy, nephropathy, and retinopathy. | DUKE | | Anti-Alzheimeran | 52217 | An agent that inhibits the progression of Alzheimer's disease, reducing beta-amyloid plaque formation and neuroinflammation. Therapeutically, it improves cognitive function and memory, commonly used in managing mild to moderate Alzheimer's disease and other neurodegenerative disorders. | DUKE | | Anti-dementia | 52217 | An agent that slows or prevents cognitive decline, reducing symptoms of dementia. It plays a biological role in neuroprotection, enhancing neuronal function and survival. Therapeutically, it is used to manage Alzheimer's disease, vascular dementia, and other neurodegenerative disorders, improving memory, cognition, and daily functioning. | DUKE | | Anti-mutagenic | | An agent that interferes with the mutagenicity of a substance, preventing DNA damage and mutations. Its biological role is to protect cells from genetic alterations, and it has therapeutic applications in cancer prevention and treatment, as well as key medical uses in reducing the risk of genetic disorders and birth defects. | DUKE | | Anti-rhinoviral | 22587 | An agent that inhibits the replication of rhinoviruses, reducing symptoms of the common cold. Therapeutically, it is used to treat and prevent rhinoviral infections, commonly used in managing respiratory illnesses such as bronchiolitis and asthma exacerbations. | DUKE | | Anti-viral | 22587 | An agent that inhibits the replication of viruses, playing a crucial role in preventing and treating viral infections. Therapeutically, anti-virals are used to manage diseases such as HIV, herpes, and influenza, reducing symptoms and slowing disease progression. Key medical uses include treating viral hepatitis, respiratory syncytial virus, and COVID-19. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Estrogenic | | An agent that mimics the effects of estrogen, regulating female reproductive processes and development. Therapeutically, estrogenic agents are used in hormone replacement therapy, contraception, and treating menopausal symptoms, as well as certain cases of osteoporosis and infertility. | DUKE | | Nitric-oxide inhibitor | 35222 | An agent that blocks the production of nitric oxide, reducing inflammation and vascular relaxation. Therapeutically, it's used to treat conditions like hypertension, angina, and septic shock, by constricting blood vessels and improving blood pressure. Key medical uses include cardiovascular and critical care applications. | DUKE | | Osteoblastogenic | | An agent that stimulates production of osteoblasts, promoting bone formation and regeneration. Its biological role involves enhancing bone growth and repair. Therapeutically, it has applications in treating osteoporosis, bone fractures, and orthopedic disorders, making it a key medical tool for managing bone-related diseases and injuries. | DUKE | | Peroxisome proliferator activated receptor gamma antagonist | 48706 | An agent that blocks the activity of PPAR_, reducing glucose and lipid metabolism regulation. Therapeutically, it may be used to treat conditions like cancer, inflammation, and metabolic disorders, with potential applications in managing obesity, diabetes, and cardiovascular diseases. | DUKE | | TNF-alpha inhibitor | 35222 | An agent that blocks the activity of tumor necrosis factor-alpha, a pro-inflammatory cytokine, reducing inflammation and immune responses. Therapeutically used to treat autoimmune diseases, such as rheumatoid arthritis, psoriasis, and Crohn's disease, by decreasing inflammation and slowing disease progression. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | CHEBI |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|